$2.85
-0.20-6.56%
al cierre: -
$2.81
-0.04-1.40%
After hour: 7:49 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Qualigen Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
ago 14
BPA
$-1.000
Ingresos trimestrales
$0.00
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
–
Analice el historial de beneficios de Qualigen Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
QLGN | Qualigen Therapeutics | -$4.70 | — | — | — | $0.00 | — | — | — | 11/13/2025 | |
QLGN | Qualigen Therapeutics | -$10.00 | — | -$1.00 | — | $0.00 | — | $0.00 | — | 08/14/2025 | |
QLGN | Qualigen Therapeutics | -$17.50 | — | -$1.82 | — | $0.00 | — | $0.00 | — | 07/21/2025 | |
QLGN | Qualigen Therapeutics | -$23.50 | — | -$1.09 | — | $0.00 | — | $0.00 | — | 06/30/2025 | |
QLGN | Qualigen Therapeutics | -$32.01 | — | -$4.70 | — | $0.00 | — | $0.00 | — | 11/14/2024 | |
QLGN | Qualigen Therapeutics | -$34.50 | — | -$10.00 | — | $1.63M | — | $0.00 | — | 08/14/2024 | |
QLGN | Qualigen Therapeutics | -$39.00 | — | -$17.50 | — | $1.61M | — | $0.00 | — | 07/02/2024 | |
QLGN | Qualigen Therapeutics | -$77.50 | -$26.00 | -$23.50 | 9.62% | $1.39M | — | $0.00 | — | 04/08/2024 | |
QLGN | Qualigen Therapeutics | -$50.00 | -$46.00 | -$32.00 | 30.43% | $1.44M | $500.00K | $0.00 | -100.00% | 11/14/2023 | |
QLGN | Qualigen Therapeutics | -$55.00 | -$26.00 | -$34.50 | -32.69% | $1.43M | $1.60M | $1.63M | 1.69% | 08/15/2023 | |
QLGN | Qualigen Therapeutics | -$60.00 | — | -$39.00 | — | $722.03K | $2.00M | $1.61M | -19.64% | 05/16/2023 | |
QLGN | Qualigen Therapeutics | -$100.00 | — | -$77.50 | — | $1.48M | — | $1.39M | — | 05/02/2023 | |
QLGN | Qualigen Therapeutics | -$50.00 | -$65.00 | -$50.00 | 23.08% | $1.16M | $1.62M | $1.44M | -11.05% | 11/15/2022 | |
QLGN | Qualigen Therapeutics | -$90.00 | — | -$55.00 | — | $1.12M | — | $1.43M | — | 08/16/2022 | |
QLGN | Qualigen Therapeutics | -$65.00 | — | -$60.00 | — | $1.90M | — | $722.03K | — | 05/13/2022 | |
QLGN | Qualigen Therapeutics | -$1.58K | -$85.00 | -$100.00 | -17.65% | $2.71M | $1.75M | $1.48M | -15.37% | 03/31/2022 | |
QLGN | Qualigen Therapeutics | $205.00 | -$95.00 | -$50.00 | 47.37% | $1.11M | $1.70M | $1.16M | -32.06% | 11/15/2021 | |
QLGN | Qualigen Therapeutics | -$205.00 | -$90.00 | -$90.00 | 0.00% | $837.71K | $1.60M | $1.12M | -30.13% | 08/17/2021 | |
QLGN | Qualigen Therapeutics | -$1.06K | — | -$65.00 | — | $904.07K | — | $1.90M | — | 05/14/2021 | |
QLGN | Qualigen Therapeutics | — | — | -$1.58K | — | — | — | $2.71M | — | 03/31/2021 | |
QLGN | Qualigen Therapeutics | — | -$65.00 | $205.00 | 415.38% | — | $2.00M | $1.11M | -44.60% | 03/31/2021 | |
QLGN | Qualigen Therapeutics | — | — | -$205.00 | — | — | — | $837.71K | — | 11/12/2020 |
Qualigen Therapeutics (QLGN) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q4 | 2024-04-08 | $-23.50 | $-26.00 | 9.62 % |
| Q3 | 2023-11-14 | $-32.00 | $-46.00 | 30.4 % |
| Q2 | 2023-08-15 | $-34.50 | $-26.00 | -32.7 % |
| Q3 | 2022-11-15 | $-50.00 | $-65.00 | 23.1 % |
Qualigen Therapeutics (QLGN) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2023-11-14 | $0 | $500.00K | -100.0 % |
| Q2 | 2023-08-15 | $1.63M | $1.60M | 1.69 % |
| Q1 | 2023-05-16 | $1.61M | $2.00M | -19.6 % |
| Q3 | 2022-11-15 | $1.44M | $1.62M | -11.1 % |
PREGUNTAS FRECUENTES
¿Cuándo Qualigen Therapeutics (NASDAQ:QLGN) publicará los resultados?
Está previsto que Qualigen Therapeutics (QLGN) presente resultados el noviembre 13, 2025. Los últimos resultados se publicaron el agosto 14, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Qualigen Therapeutics (NASDAQ:QLGN)?
El BPA real fue de $-1.00, que no alcanzó la estimación de $0.00.
¿Cuáles fueron los ingresos de Qualigen Therapeutics (NASDAQ:QLGN)?
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.